SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending amidst escalating geopolitical tensions in the Middle East, with community discussion heavily focused on reports of a de facto closure or severe disruption in the Strait of Hormuz, a critical global oil chokepoint. This situation is fueling expectations of significantly higher oil prices and a potential short squeeze, leading many to anticipate substantial gains for low-float energy stocks like INDO.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending amid heightened geopolitical tensions concerning potential military action involving Iran and threats to the Strait of Hormuz, prompting widespread community discussion about imminent disruptions to global oil supply and a significant surge in crude prices. Many view energy stocks as a critical hedge, actively buying into XOM in anticipation of substantial gains, though some caution against an overextended market.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is surging amid intensifying Middle East tensions and threats to oil shipping lanes, driving bullish sentiment across the energy sector. The community is actively discussing its high short interest and limited float, fueling expectations of a major short squeeze, further amplified by its recent debt reduction from an asset sale.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is experiencing strong community engagement and price momentum, fueled by anticipation for the upcoming 4/20 event. The community champions its role as the 'culture coin' for the global cannabis movement, highlighting its long-term vision for education, Web3 integration, and advocacy for the broader cannabis and hemp industries on Solana.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is trending as escalating Middle East tensions, including US-Israel strikes on Iran and subsequent disruptions to tanker traffic through the Strait of Hormuz, spark fears of an oil supply shock. The community is widely discussing a significant rotation into the energy sector, anticipating a strong upside for oil and related equities.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending amidst escalating geopolitical tensions, particularly surrounding potential military action involving Iran, which is driving significant community discussion around increased defense spending and has prompted updated analyst price targets for the major defense contractor.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

The United States Oil Fund ($USO) is trending due to escalating Middle East tensions and reports of stalled tanker traffic through the critical Strait of Hormuz, fueling widespread community discussion about potential oil supply disruptions and a sharp rise in prices.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is a focal point of market discussion, as high expectations for surging AI revenue from hyperscaler infrastructure spending ahead of its upcoming earnings report clash with broader sentiment around chip valuations and geopolitical uncertainties.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Escalating geopolitical tensions in the Middle East, particularly concerning the Strait of Hormuz, are rapidly disrupting global LNG supply and driving up prices. The community is actively discussing Venture Global's strategic position to capitalize on these supply shifts with its expanding liquefaction capacity and owned tankers, alongside anticipation for strong earnings and a potential short squeeze.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics is trending as its recent positive guidance and robust Tyvaso DPI sales have driven a significant stock rally and analyst upgrades. However, community conversations are animated by the introduction of its new 'Tresmi' soft mist inhaler, with some viewing it as a category-disrupting innovation for pulmonary therapies, while others debate its potential to cannibalize existing products and impact partner royalties.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis

Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis Vanda Pharmaceuticals Announces FDA...

AnaptysBio (NASDAQ:ANAB) Reaches New 1-Year High - Time to Buy?

AnaptysBio (NASDAQ:ANAB) Sets New 12-Month High - Still a Buy...

Skandinaviska Enskilda Banken AB publ Has $4.45 Million Stock Position in AnaptysBio, Inc. $ANAB

Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 333.1% in the 3rd quarter, according to its most recent disclosure with the...

AnaptysBio, Inc. $ANAB Stock Holdings Trimmed by GSA Capital Partners LLP

GSA Capital Partners LLP lowered its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 46.6% during the 3rd quarter, according to its most recent disclosure with the Securities...

AnaptysBio (ANAB) to Release Quarterly Earnings on Thursday

AnaptysBio (NASDAQ:ANAB) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Insider Selling: AnaptysBio (NASDAQ:ANAB) Insider Sells 10,000 Shares of Stock

AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) insider Eric Loumeau sold 10,000 shares of AnaptysBio stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an...

AnaptysBio (NASDAQ:ANAB) Insider Sells $540,000.00 in Stock

AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) insider Eric Loumeau sold 10,000 shares of the stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $54.00...

AnaptysBio Details Q2 Royalty Spin, Jemperli Growth and ANB033 Celiac Data Coming in Q4

AnaptysBio (NASDAQ:ANAB) leadership outlined plans to separate its royalty business from its clinical-stage biopharma operations, while also discussing key revenue drivers tied to GSK's Jemperli...

AnaptysBio (NASDAQ:ANAB) Sets New 52-Week High - Should You Buy?

AnaptysBio (NASDAQ:ANAB) Sets New 1-Year High - Time to Buy...

AnaptysBio Teases Q2 Split Into RoyaltyCo and Biopharma Spin, Flags Jemperli and Pipeline Catalysts

AnaptysBio (NASDAQ:ANAB) outlined plans to separate its business into two publicly traded entities and reviewed upcoming clinical and commercial catalysts during a discussion at the Guggenheim...

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

AnaptysBio Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.86	--	--	N/A
Q3 '25	-$1.21	$0.52	142.83%	BEAT
Q2 '25	-$1.55	-$1.34	13.59%	BEAT
Q1 '25	-$1.25	-$1.28	-2.15%	MISSED
Q4 '24	-$1.62	-$0.72	55.54%	BEAT

ANAB
AnaptysBio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest ANAB News

ANABAnaptysBio Inc